Tumor Marker Protocols - Hanausek, Margaret; Walaszek, Zbigniew; SpringerLink (Online service) (Totowa, NJ : Humana Press : Imprint: Humana, 1998)
Multiple Markers: Principles and Guidelines -- Integrating Multiple Clinical Tests to Increase Predictive Power -- Statistical Considerations in the Analysis of Tumor Markers -- Selection and Development of Biomarkers for Bladder Cancer -- Clinical Application of Tissue and Serum Markers in Breast Cancer -- Immunodiagnosls of Cancer: Serum and Tissue Markers -- Serum and Tissue Biomarkers in the Prognosis and Treatment of Breast Cancer -- The Oncofetal Protein p65 in Breast Cancer Detection -- Determination of Tumor Ferritin Concentration in Breast Cancer -- Immunodiagnosis of Childhood Malignancies -- Immunohistochemical Evaluation of Biomarkers in Prostatic and Colorectal Neoplasia -- Factors Affecting Immunohistochemical Evaluation of Biomarker Expression in Neoplasia -- Instrumentation, Accuracy, and Quality Control Issues in Development of Quantitative Fluorescence-Image Analysis (QFIA) -- Cytogenetic Markers -- Cytogenetics as a Diagnostic Aid for Childhood Hematologic Disorders -- Preparation of Metaphase Chromosomes for Cytogenetic Analysis -- Chromosome Staining and Banding Techniques -- Fluorescence In Situ Hybridization to Chromosomes -- Detection of Rearrangements in the bcl-2 Gene Using the Polymerase Chain Reaction -- Molecular Markers -- Applications of Tissue Microdissection in Molecular Pathology -- EWS Gene Fusions as Diagnostic Markers in Sarcomas -- p53 Detection in Breast Cancer -- Use of the Polymerase Chain Reaction Technique to Detect the t(14;18) Translocation in Lymphoid Tissue -- Detection of ras Gene Mutations Using Oligonucleotide Ligation Technology -- Detection of Prostate-Cancer Cells in Blood and Bone Marrow by RT-PCR -- Quantitative, Competitive RT-PCR Analysis of Biomarkers in the Study of Neoplasia -- Differential Display to Define Molecular Markers and Genes That Mediate Malignancy -- Miscellaneous Markers and Early Detection of Cancer -- Transforming Growth Factor Beta -- Anti-HMdU Autoantibodies in Human Sera as a Biomarker of Cancer Risk -- A Scientific Basis for Cancer Prevention -- Aberrant Crypt Foci System to Study Cancer Preventive Agents in the Colon -- Strain-Dependent Differences in the Expression of the Oncofetal Protein p65 in Mice Susceptible and Resistant to Chemical Carcinogenesis -- d-Glucaric Acid as a Prospective Tumor Marker.
Keywords: Pathology; Pathology